|
Originally published In Press as doi:10.1074/jbc.M513304200 on June 22, 2006
J. Biol. Chem., Vol. 281, Issue 37, 26865-26875, September 15, 2006
Toll-like Receptor-2 Is Essential for the Development of Palmitate-induced Insulin Resistance in Myotubes*
Joseph J. Senn1
From the
Department of Pediatrics, Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina 29425
Fatty acids can activate proinflammatory pathways leading to the development of insulin resistance, but the mechanism is undiscovered. Toll like receptor 2 (TLR2) recognizes lipids, activates proinflammatory pathways, and is genetically associated with inflammatory diseases. This study aimed to examine the role of TLR2 in palmitate-induced insulin resistance in C2C12 myotubes. Treatment with palmitate rapidly induced the association of myeloid differentiation factor 88 (MyD88) with the TLR2 receptor, activated the stress-linked kinases p38, JNK, and protein kinase C, induced degradation of I B , and increased NF- B DNA binding. The activation of these pathways by palmitate was sensitive and temporally regulated and occurred within the upper physiologic range of saturated fatty acid concentrations in vivo, suggesting a receptor-mediated event and not simple lipotoxicity. When compared with an equimolar concentration of palmitate, fibroblast-stimulating lipopeptide-1, a known TLR2 ligand, was a slightly more potent activator of signal transduction and interleukin (IL)-6 production. Palmitate inhibited insulin signal transduction in C2C12 cells beginning 12 h after exposure and reached a maximum at 1216 h. An antagonist TLR2 antibody, mAb 2.5, led to a 5060% decrease in palmitate-induced IL-6 production and partially restored insulin signal transduction, whereas an isotype-matched control antibody had no effect. RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production. This study provides strong evidence that TLR2 mediates the initial events of fatty acid-induced insulin resistance in muscle.
Received for publication, December 14, 2005
, and in revised form, June 9, 2006.
* This study was supported by the Department of Pediatrics, Medical University of South Carolina. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Pediatric Endocrinology, Medical University of South Carolina, Rm. 316, Clinical Science Bldg., 96 Jonathan Lucas St., Charleston, SC 29425; E-mail: sennj{at}musc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q. Zhou, S. E. Leeman, and S. Amar
Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses
PNAS,
June 30, 2009;
106(26):
10740 - 10745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-E. Lee, S. Kehlenbrink, H. Lee, M. Hawkins, and J. S. Yudkin
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Am J Physiol Endocrinol Metab,
June 1, 2009;
296(6):
E1210 - E1229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Varma, A. Yao-Borengasser, N. Rasouli, G. T. Nolen, B. Phanavanh, T. Starks, C. Gurley, P. Simpson, R. E. McGehee Jr., P. A. Kern, et al.
Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action
Am J Physiol Endocrinol Metab,
June 1, 2009;
296(6):
E1300 - E1310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Samokhvalov, P. J. Bilan, J. D. Schertzer, C. N. Antonescu, and A. Klip
Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells
Am J Physiol Endocrinol Metab,
January 1, 2009;
296(1):
E37 - E46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. H. Hommelberg, J. Plat, R. C. J. Langen, A. M. W. J. Schols, and R. P. Mensink
Fatty acid-induced NF-{kappa}B activation and insulin resistance in skeletal muscle are chain length dependent
Am J Physiol Endocrinol Metab,
January 1, 2009;
296(1):
E114 - E120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Caricilli, P. H Nascimento, J. R Pauli, D. M L Tsukumo, L. A Velloso, J. B Carvalheira, and M. J A Saad
Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet
J. Endocrinol.,
December 1, 2008;
199(3):
399 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nieto-Vazquez, S. Fernandez-Veledo, C. de Alvaro, and M. Lorenzo
Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle
Diabetes,
December 1, 2008;
57(12):
3211 - 3221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Kim, M. Pham, E. Maloney, N. O. Rizzo, G. J. Morton, B. E. Wisse, E. A. Kirk, A. Chait, and M. W. Schwartz
Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin Resistance
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2008;
28(11):
1982 - 1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Reyna, S. Ghosh, P. Tantiwong, C.S. R. Meka, P. Eagan, C. P. Jenkinson, E. Cersosimo, R. A. DeFronzo, D. K. Coletta, A. Sriwijitkamol, et al.
Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects
Diabetes,
October 1, 2008;
57(10):
2595 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ghanim, P. Mohanty, R. Deopurkar, C. Ling Sia, K. Korzeniewski, S. Abuaysheh, A. Chaudhuri, and P. Dandona
Acute Modulation of Toll-Like Receptors by Insulin
Diabetes Care,
September 1, 2008;
31(9):
1827 - 1831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Holland and S. A. Summers
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
Endocr. Rev.,
June 1, 2008;
29(4):
381 - 402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Martinez, K. Tanabe, C. Cras-Meneur, N. A. Abumrad, E. Bernal-Mizrachi, and M. A. Permutt
Inhibition of Foxo1 Protects Pancreatic Islet {beta}-Cells Against Fatty Acid and Endoplasmic Reticulum Stress-Induced Apoptosis
Diabetes,
April 1, 2008;
57(4):
846 - 859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Frost and C. H. Lang
Regulation of muscle growth by pathogen-associated molecules
J Anim Sci,
April 1, 2008;
86(14_suppl):
E84 - E93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2008;
294(3):
R673 - R680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-a Kim, Y. Wei, and J. R. Sowers
Role of Mitochondrial Dysfunction in Insulin Resistance
Circ. Res.,
February 29, 2008;
102(4):
401 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Polkinghorne, Q. Lau, G. J. Cooney, E. W. Kraegen, and M. E. Cleasby
Local activation of the I{kappa}K-NF-{kappa}B pathway in muscle does not cause insulin resistance
Am J Physiol Endocrinol Metab,
February 1, 2008;
294(2):
E316 - E325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M.L. Tsukumo, M. A. Carvalho-Filho, J. B.C. Carvalheira, P. O. Prada, S. M. Hirabara, A. A. Schenka, E. P. Araujo, J. Vassallo, R. Curi, L. A. Velloso, et al.
Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance
Diabetes,
August 1, 2007;
56(8):
1986 - 1998.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|